8th SCI / RSC symposium on kinase inhibitor design
12 Dec 2017
Venue: Babraham Research Campus, Cambridge, UK
Date: Monday 14 - Tuesday 15 May 2018
With more than 25 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 8th RSC / SCI symposium on kinases will encompass case studies of ongoing programmes, plus those that were successful in the past. A range of topics including CNS kinase inhibitors, allosteric inhibitors and non-oral delivery methods will be covered, along with views and perspectives on the future of kinase inhibitor research.
Contributions for a poster exhibition are invited from those working in all areas of kinase research, development, commercialisation and use. A one-page abstract should be submitted to the Secretariat by Friday 30 March 2018. When submitting posters, please indicate whether you would be prepared to give a single-slide summary of your poster in a formal presentation session.
This is a great opportunity for all scientists interested in furthering their knowledge of kinases and growing their professional development network. The event will have wide audience appeal to those of the drug discovery community eager to understand how enzyme inhibitor programmes are approached and executed across the pharmaceutical industry. Discounted rates will be available for RSC and SCI student members, and some student bursaries will be available on application, so register your interest today!
- Kinase 2018: towards new frontiers – 8th SCI/RSC Symposium on kinase inhibitor design – book now!
Poster abstract deadline: Friday 30 March 2018
- Fine Chemicals Group